Ultralife Corp. (NASDAQ: ULBI) reported Q4 EPS of $0.10, $0.03 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $31.4 million versus the consensus estimate of $37.6 million.

For earnings history and earnings-related data on Ultralife Corp. (ULBI) click here.

Earnings